However, how the close functioning of the progesterone/PR and prolactin/PRLR signaling axes that drive the lactogenic/lipogenic phenotypic outcomes in normal mammary gland [63] might be altered in breast cancer tissues remains largely unexplored. The gene discussed is PRLR; the disease is breast cancer.